Search Results - "Emiliani, Alessandra"
-
1
Adjuvant chemotherapy in resected colon cancer: When, how and how long?
Published in Surgical oncology (01-09-2019)“…The benefit of adjuvant chemotherapy has been clearly established in the adjuvant setting for node-positive colon cancer. A number of trials in the adjuvant…”
Get full text
Journal Article -
2
Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients
Published in Cancers (31-12-2020)“…The pathophysiology of cancer anorexia is complex and serum biomarkers, including growth and differentiation factor(s) (GDF), may be modulated. We explored the…”
Get full text
Journal Article -
3
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
Published in Frontiers in oncology (21-02-2023)“…Right- (R) and left-sided (L) metastatic colorectal cancer (mCRC) exhibit different clinical and molecular features. Several retrospective analyses showed that…”
Get full text
Journal Article -
4
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study
Published in Current oncology (Toronto) (01-06-2023)“…Patients with refractory mCRC rarely undergo third-line or subsequent treatment. This strategy could negatively impact their survival. In this setting,…”
Get full text
Journal Article -
5
Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC
Published in ERJ open research (01-01-2017)“…In small-cell lung cancer (SCLC), the role of chemotherapy and radiotherapy is well established. Large-cell neuroendocrine carcinoma (LCNEC) shares several…”
Get full text
Journal Article -
6
An unusual presentation of multiple cavitated lung metastases from colon carcinoma
Published in BMC medical imaging (31-05-2011)“…Consolidation with or without ground-glass opacity is the typical radiologic finding of lung metastases of adenocarcinoma from the gastrointestinal tract. Lung…”
Get full text
Journal Article -
7
Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site
Published in Case reports in oncological medicine (01-01-2013)“…Merkel cell carcinoma (MCC) is an extremely rare primary neuroendocrine neoplasm of the skin that shows aggressive behavior and a poor prognosis. We report a…”
Get full text
Journal Article -
8
Plasma enterobacterial ClpB levels and ClpB- and α-MSH–reactive immunoglobulins in lung cancer patients with and without anorexia
Published in Nutrition (Burbank, Los Angeles County, Calif.) (01-10-2020)“…Anorexia represents a common and debilitating clinical problem in patients with several forms of cancer, in particular lung cancer, but its mechanisms are not…”
Get full text
Journal Article -
9
The 5-Ws of immunotherapy in head and neck cancer
Published in Critical reviews in oncology/hematology (01-09-2020)“…[Display omitted] The immune checkpoint inhibitors, a class of drugs able to block immune suppressive pathways in order to prime an anticancer immunity,…”
Get full text
Journal Article -
10
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer
Published in Cancers (24-07-2019)“…Molecular alterations are not randomly distributed in colorectal cancer (CRC), but rather clustered on the basis of primary tumor location underlying the…”
Get full text
Journal Article -
11
Cancer anorexia: hypothalamic activity and its association with inflammation and appetite‐regulating peptides in lung cancer
Published in Journal of cachexia, sarcopenia and muscle (01-02-2017)“…Background Energy homeostasis is mediated by the hypothalamus, whose inflammation‐induced functional derangements contribute to the onset of anorexia in…”
Get full text
Journal Article -
12
Efficacy of third-line anti-EGFR-based treatment (tx) versus (vs) Regorafenib/TAS-102 (R/T) according to primary tumor site in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts)
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 4082 Background: Right- (R) and left-sided (L) mCRCs exhibit different clinical and molecular features. Several retrospective analyses showed…”
Get full text
Journal Article -
13
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis
Published in Cancers (01-12-2023)“…: Patients with refractory metastatic colorectal cancer (mCRC) rarely receive third-line or further treatment. In this context, regorafenib (R) and…”
Get full text
Journal Article -
14
Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study
Published in Cancers (16-05-2020)“…Background: The optimal anti-angiogenic strategy as second-line treatment in wild-type metastatic colorectal cancer (mCRC) treated with anti-EGFR (Epidermal…”
Get full text
Journal Article -
15
Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
Published in Cardiology (01-01-2010)“…Capecitabine is an oral fluoropyrimidine which is transformed to 5-Fluorouracil inside tumor cells, where it achieves high drug concentrations. Capecitabine is…”
Get more information
Journal Article